Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

Search results (105)

« Back to Publications

Diurnal variation in neurovascular coupling and the impact of sleep quality: a UK Biobank study.

Yang S. and Webb AJS., (2026), Sleep, 49

Stroke Action Plan for Europe 2018–2030 (SAP-E): mid-term review and update

Christensen H. et al, (2026), European Stroke Journal, 11

Optimal markers of treatment response to vasodilatory drugs in small vessel disease: An OxHARP trial analysis.

Webb AJS. et al, (2026), Int J Stroke, 21, 100 - 109

White matter hyperintensities are independently associated with systemic vascular aging and cerebrovascular dysfunction.

Webb AJ. et al, (2025), Int J Stroke, 20, 581 - 589

Clinical Relevance of 'Cap' and 'Track' Development after Recent Small Subcortical Infarct.

Cheng Y. et al, (2025), Ann Neurol, 97, 942 - 955

Reduced neurovascular coupling is associated with increased cardiovascular risk without established cerebrovascular disease: A cross-sectional analysis in UK Biobank.

Yang S. and Webb AJS., (2025), J Cereb Blood Flow Metab, 45, 897 - 907

Early neurological deterioration in acute lacunar ischemic stroke: Systematic review of incidence, mechanisms, and prospects for treatment.

Werring DJ. et al, (2025), Int J Stroke, 20, 7 - 20

Carotid Blood Flow Assessment during Dynamic Respiratory Maneuvers Demonstrates a Shift toward Vasoconstriction with Increasing Age

Llwyd O. et al, (2025), JOURNAL OF MEDICAL ULTRASOUND

Cerebrovascular Effects of Sildenafil in Small Vessel Disease: The OxHARP Trial

Webb AJS. et al, (2024), Circulation Research, 135, 320 - 331

Circadian and Diurnal Regulation of Cerebral Blood Flow.

Webb AJS. et al, (2024), Circ Res, 134, 695 - 710

Pulmonary Hypertension: Intensification and Personalization of Combination Rx (PHoenix): A phase IV randomized trial for the evaluation of dose-response and clinical efficacy of riociguat and selexipag using implanted technologies.

Varian F. et al, (2024), Pulm Circ, 14

Associations between neurovascular coupling and cerebral small vessel disease: A systematic review and meta-analysis.

Yang S. and Webb AJS., (2023), Eur Stroke J, 8, 895 - 903

Effect of blood pressure-lowering agents on microvascular function in people with small vessel diseases (TREAT-SVDs): a multicentre, open-label, randomised, crossover trial.

Kopczak A. et al, (2023), Lancet Neurol, 22, 991 - 1004

Consensus Recommendations for Standardized Data Elements, Scales, and Time Segmentations in Studies of Human Circadian/Diurnal Biology and Stroke

Saver JL. et al, (2023), Stroke, 54, 1943 - 1949

Association of gout with brain reserve and vulnerability to neurodegenerative disease

Topiwala A. et al, (2023), Nature Communications, 14

Load More

1
2
3
4
5
6
7